Holobiome: Funding, Investors & Team (Nov 2026)
Holobiome is a company that specializes in developing therapies for diseases affecting the enteric and central nervous systems. Using microbiome-based treatments, the company aims to address a range of mental health issues, as well as metabolism and immune responses. Founded in 2015, Holobiome is located in Cambridge, Massachusetts.
Holobiome has raised $26.6M across 4 funding rounds on record, the most recent a Seed of $10.0M announced in Jul 2026.
That round is above the $5.0M median round size for Health Care companies tracked on FundedIQ over the last two years.
Holobiome Company Profile and Key Stats
Latest funding round on record: Jul 2026.
Holobiome Funding Rounds
Holobiome raised $1.0M in a Grant announced in Oct 2021.
2.4 years later, an undisclosed round of $6.6M was announced in Mar 2024.
7 months later, a Seed of $9.0M was announced in Oct 2024.
1.8 years later, a Seed of $10.0M was announced in Jul 2026.
Holobiome Investors
11 investors are recorded in total; the 5 named above are those the record identifies.
Holobiome Founders and Leadership Team
Contact details for the Holobiome team: 1 of 2 have an email address on file, 2 have a LinkedIn profile.
Start 14-day free trial →Holobiome Funding Compared to Other Health Care Startups
Holobiome's latest round of $10.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Holobiome in Health Care and Cambridge
Companies Similar to Holobiome
ReferWell is a digital health company based in the New York area that makes use of the referable moment, or…
Physician-led medical device company focused on developing enhanced electroporation therapy for advanced…
SymKardia is healthcare manufacturing company that develops medical device to treat cardiac arrhythmias.
We are dedicated to revolutionizing gastric bypass. From the procedure to the recovery, our skilled team of…
BEKhealth harnesses its AI-powered chart abstraction and patient-matching platform to help organizations…
Treso operates as a financial software provider that develops an integrated financial operating system…
Optain produces medical tools and technology with the aim of providing healthcare access to everyone,…
Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…
PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…
General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…
Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…
SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…
Holobiome Funding FAQs
What does Holobiome do?
Holobiome is a company that specializes in developing therapies for diseases affecting the enteric and central nervous systems. Using microbiome-based treatments, the company aims to address a range of mental health issues, as well as metabolism and immune responses. Founded in 2015, Holobiome is located in Cambridge, Massachusetts.
How much funding has Holobiome raised?
Holobiome has raised $26.6M across 4 rounds on record. The most recent is a Seed of $10.0M announced in Jul 2026.
When did Holobiome last raise funding?
Holobiome's most recent funding round on record is a Seed of $10.0M, announced in Jul 2026.
Who has invested in Holobiome?
Investors on record for Holobiome include Valor Equity Partners, Astanor Ventures, iSelect Fund, Able Partners, Satori Capital. FundedIQ records 11 investors in total.
Who founded Holobiome?
FundedIQ lists Michael Fleur (Cofounder and President), Philip Strandwitz (Founder) at Holobiome.
Where is Holobiome headquartered?
Holobiome is based in Cambridge, Massachusetts, United States.
How many employees does Holobiome have?
Holobiome is in the 1-10 employee band.
When was Holobiome founded?
Holobiome was founded in 2015.
How does Holobiome's funding compare to other Health Care startups?
Holobiome's latest round of $10.0M is above the $5.0M median round size for Health Care companies on FundedIQ across 3,662 tracked companies over the last two years.
About FundedIQ's Holobiome Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Holobiome is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.